Stock


Amgros has its own stocks. This helps further secure supplies of medicines. It provides greater flexibility, because we can supplement hospital pharmacies' own stocks, and we can buy larger batches of supply-critical medicines.

Amgros has its own stocks. This helps further secure supplies of medicines. It provides greater flexibility, because we can supplement hospital pharmacies' own stocks, and we can buy larger batches of supply-critical medicines.

Before the outbreak of the pandemic, Denmark basically never needed to have more medicines in stock than the current demand. But the COVID-19 pandemic changed this. No one knew specifically which supply challenges we could have to face. Therefore, the Danish Medicines Agency asked Amgros to increase our stocks to ensure that, as far as possible, Danish patients could get the medicines they needed.

We worked closely with suppliers and hospital pharmacies to build up our stocks. This means that some stocks are held in decentral locations, either at the suppliers or at the hospital pharmacies, depending on what is most practical in terms of production and logistics.

ALL PARTIES HAVE HELPED SECURE SUPPLIES

The fact that we have built up and expanded our own stocks, while the hospital pharmacies and suppliers have also expanded their stocks, means that, at no time whatsoever during the pandemic have we faced a shortage of critical medicines at public hospitals. Furthermore, in 2020, we managed to reduce the number of back orders of hospital medicines by 20-30%. In contrast, back orders of medicines for public hospitals in Denmark have generally remained constant over the past years.

In practice, we have worked using different lists of needs in our efforts to secure supplies of medicines. And we have done this in collaboration with clinical pharmacologists from the five regions, the eight hospital pharmacies and the Danish Medicines Agency.

Everyone has helped identify the medicines Amgros has to buy more of in this unusual situation. In this way, we have not only ensured supplies of basic medicines for hospitals; we have also ensured supplies of medicines to treat patients with critical illness and patients with COVID-19.

Time will show how our stocks of medicines will develop after the pandemic. Of course, we need to adapt to the situation as it evolves. However, one thing is certain. We will continue to have products on our own shelves to secure supplies of medicines.


Pandemic confirms that Denmark has a strong setup

It is essential to secure continued supplies of pharmaceuticals to Danish hospitals during the corona pandemic. It is also vital that we build up a buffer stock. This is only feasible through close cooperation between Danish hospital pharmacies, the regions, organisations, authorities and pharmaceutical companies.

Link to article

READ MORE

Stock

Procurement and supply

Amgros informs the hospital pharmacies when we have set up an agreement to purchase a pharmaceutical. After this, hospital pharmacies send their purchase orders to the supplier

READ MORE
Stock

Back orders

Back orders of pharmaceuticals is a growing challenge globally. The problem arises if a supplier cannot meet demand from hospital pharmacies.

READ MORE

Paul Wiberg-Jørgensen

Head of Procurement and Supply

I’m responsible for Amgros’ procurement, stocks, and distribution. By developing and optimising the supply chain, the Procurement and Supplies Department helps to ensure that we get more cost-effective health solutions.